Ingevity (NYSE:NGVT) Releases FY 2026 Earnings Guidance

Ingevity (NYSE:NGVT) issued an update on its FY 2026 earnings guidance on Wednesday. The company provided earnings per share guidance of 5.000-5.450 for the period, compared to the consensus earnings per share estimate of 4.950. The company issued revenue guidance of $1.1 billion-$1.2 billion, compared to the consensus revenue estimate of $1.1 billion.

Analysts Set New Price Targets

Several research analysts recently issued reports on the stock. Wall Street Zen raised shares of Ingevity from a “buy” rating to a “strong-buy” rating in a research report on Tuesday, July 7th. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Ingevity in a report on Friday, July 17th. Two investment analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus target price of $80.00.

Ingevity Price Performance

Shares of NYSE:NGVT traded down $3.41 on Wednesday, hitting $71.08. The stock had a trading volume of 387,158 shares, compared to its average volume of 294,583. The firm’s 50 day moving average price is $71.43 and its 200-day moving average price is $70.86. The company has a debt-to-equity ratio of 27.83, a quick ratio of 0.92 and a current ratio of 1.42. Ingevity has a twelve month low of $39.74 and a twelve month high of $79.29. The company has a market capitalization of $2.47 billion, a price-to-earnings ratio of -20.02 and a beta of 1.16.

Ingevity (NYSE:NGVT) last announced its earnings results on Wednesday, July 29th. The company reported $1.74 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.33 by $0.41. Ingevity had a negative net margin of 10.55% and a positive return on equity of 207.82%. The business had revenue of $314.10 million during the quarter, compared to analysts’ expectations of $312.20 million. Ingevity has set its FY 2026 guidance at 5.000-5.450 EPS. On average, equities research analysts predict that Ingevity will post 5.05 earnings per share for the current year.

Insider Buying and Selling at Ingevity

In other news, SVP Terrance M. Dyer sold 496 shares of the firm’s stock in a transaction that occurred on Thursday, May 28th. The shares were sold at an average price of $68.49, for a total transaction of $33,971.04. Following the completion of the sale, the senior vice president owned 7,202 shares of the company’s stock, valued at approximately $493,264.98. This trade represents a 6.44% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Insiders own 0.88% of the company’s stock.

Institutional Investors Weigh In On Ingevity

Large investors have recently bought and sold shares of the business. Advisory Services Network LLC raised its position in Ingevity by 4.4% in the 3rd quarter. Advisory Services Network LLC now owns 6,947 shares of the company’s stock valued at $383,000 after purchasing an additional 293 shares during the last quarter. Amundi boosted its stake in Ingevity by 4.8% in the third quarter. Amundi now owns 6,626 shares of the company’s stock worth $364,000 after purchasing an additional 302 shares in the last quarter. Geneos Wealth Management Inc. grew its holdings in shares of Ingevity by 85.8% during the second quarter. Geneos Wealth Management Inc. now owns 838 shares of the company’s stock worth $36,000 after purchasing an additional 387 shares during the last quarter. Global Retirement Partners LLC bought a new stake in shares of Ingevity during the fourth quarter worth $27,000. Finally, CANADA LIFE ASSURANCE Co increased its stake in shares of Ingevity by 1.6% in the fourth quarter. CANADA LIFE ASSURANCE Co now owns 30,116 shares of the company’s stock valued at $1,782,000 after buying an additional 485 shares in the last quarter. 91.59% of the stock is currently owned by institutional investors.

About Ingevity

Ingevity Corporation, traded as NGVT, is a specialty chemicals and performance materials company headquartered in North Charleston, South Carolina. The company operates two primary business units: Performance Chemicals and Performance Materials. The Performance Chemicals segment produces and markets specialty chemicals derived largely from wood and other natural feedstocks, including rosin acids, tall oil fatty acids and esters, as well as specialty petroleum resins. These products serve a broad range of industries, including paper, adhesives, coatings, oilfield drilling and consumer goods.

The Performance Materials segment develops and manufactures activated carbon products and composites for applications such as automotive emissions control, industrial air and water purification, and spill containment.